News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
8h
DPA International on MSNEMA recommends approval of additional Alzheimer's treatmentThe European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...
A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.
Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...
The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...
While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results